Seeking Alpha

NuVasive (NUVA +7.2%) shares are upgraded to Outperform by JMP Securities on signs that the...

NuVasive (NUVA +7.2%) shares are upgraded to Outperform by JMP Securities on signs that the fundamentals of the slumping market for spine products have turned a corner. The firm says NUVA is well positioned to benefit from what should prove a long-term trend because of its focus on minimally invasive surgery and its acquisition of Impulse Monitoring.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs